Abstract The invention pertains to a probiotic agent designed to modulate the gut hormone GLP-1 levels, encompassing the Lacticaseibacillus rhamnosus LRa05 strain (CGMCC No.1.12734) and its application in obesity treatment. The LRa05 strain significantly enhances GLP-1 expression in intestinal endocrine cells, reducing...

The global GLP-1 analogues market is poised for substantial growth, projected to expand from USD 47.4 billion in 2024 to USD 471.1 billion by 2032, at a robust CAGR of 33.2%. Key drivers include the drugs' efficacy in managing diabetes and obesity, driving high demand and clinical research advancements. The market is...

The report "GLP-1 Analogues Market by Product (Ozempic, Rybelsus, Saxenda, Wegovy, Mounjaro, Zepbound, Victoza, Trulicity), Format (Single dose, Multi-dose, Tablets), ROA (Subcutaneous, Oral), Indication (Diabetes, Obesity) - Global Forecast to 2032", is projected to reach USD 471.1 billion by 2032 from USD 47.4 billion...

Polaris Market Research has published a brand-new report titled GLP-1 Receptor Agonist Market Size, Share, & Industry Analysis Report: By Route of Administration (Parenteral and Oral), By Product, By Application, By Distribution Channel, and By Region – Market Forecast, 2025–2034 that includes extensive information and...

Weight loss injections have become a popular medical solution for individuals struggling with obesity and metabolic disorders. With several injectable options now available, choosing the right one can be confusing. This detailed comparison of Mounjaro Injection in Islamabad vs Other Weight Loss Injections will help you...

Semaglutide Market Analysis The Semaglutide market is projected to reach US$ 61.7 billion by 2033, up from US$ 27.15 billion in 2024, growing at a CAGR of 9.55% during 2025–2033. The growth is driven by rising prevalence of obesity and type 2 diabetes, the efficacy of semaglutide in glycemic control and weight...

Perimenopause is a transitional phase that brings complex hormonal changes, stubborn weight gain, insulin resistance, mood swings, and disrupted metabolism. For many women, traditional diet and exercise no longer work the way they once did. This is where Mounjaro 2.5 mg is gaining attention as a potential tool to support...

Explosive Growth in the Global Weight Loss Market Driven by Obesity Epidemic and Digital Innovation According to Renub Research, the Weight Loss Market is projected to reach a staggering US$ 590.13 Billion by 2033, growing from US$ 297.43 Billion in 2024—registering a robust CAGR of 7.91% from 2025 to 2033. This...

Saudi Arabia Diabetes Drug Market Size & Insights The Saudi Arabia Diabetes Drug Market size was valued at around USD 2 billion in 2024 and is projected to reach USD 3.4 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 9% during the forecast period (2025-30). The Global Saudi Arabia...

Semaglutide is widely recognized for its effectiveness in managing type 2 diabetes and aiding in weight loss. However, one of the side effects that some users experience is fatigue. If you are feeling unusually tired while taking this medication, you are not alone. In this article, we will discuss why semaglutide may...